Watson, Ian <br/><br/>
NICE guidance on pembrolizumab for advanced melanoma.  [electronic resource] 

 -  The Lancet. Oncology  Jan 2016 
 - 21-2 p.  digital 
<br/><br/> Publication Type: News 
<br/><br/><label>ISSN: </label>1474-5488 
<br/><br/><label>Standard No.: </label>10.1016/S1470-2045(15)00547-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal, Humanized--therapeutic use<br/>Antineoplastic Agents--therapeutic use<br/>Cost-Benefit Analysis<br/>Disease-Free Survival<br/>Humans<br/>Melanoma--drug therapy<br/>Practice Guidelines as Topic<br/>Randomized Controlled Trials as Topic<br/>Survival Rate<br/>United Kingdom